Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Al B Benson

Showing results (191-200 of 350) with videos related to

Pageof 35
Sort By:
Pancreas|October 18, 2016
Precision Medicine and Pancreatic Cancer: A Gemcitabine Pathway ApproachJames J Farrell, Jennifer Moughan, Jonathan L Wong, et al.
American Journal of Cancer Research|April 6, 2019
Magnetic resonance imaging monitoring therapeutic response to dendritic cell vaccine in murine orthotopic pancreatic cancer modelsLiang Pan, Na Shang, Junjie Shangguan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2004
American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancerAl B Benson, Deborah Schrag, Mark R Somerfield, et al.
Journal of Oncology Practice|January 10, 2019
Piloting a Financial Counseling Intervention for Patients With Cancer Receiving ChemotherapySheetal M Kircher, Jessica Yarber, Josh Rutsohn, et al.
4Open|January 19, 2026
Safety and Efficacy of amplitude-modulated radiofrequency electromagnetic fields in advanced hepatocellular carcinomaArthur W Blackstock, Al B Benson, Masatoshi Kudo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2004
Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114Jeffrey A Meyerhardt, Joel E Tepper, Donna Niedzwiecki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803Shuji Ogino, Jeffrey A Meyerhardt, Natsumi Irahara, et al.
Cancer|July 2, 2003
The correlation between patient characteristics and expectations of benefit from Phase I clinical trialsKevin P Weinfurt, Liana D Castel, Yun Li, et al.
Hepatology (Baltimore, Md.)|November 24, 2011
Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: analyzing patterns of progression in 285 patientsSeanthan Senthilnathan, Khairuddin Memon, Robert J Lewandowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2010
Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803Kimmie Ng, Jeffrey A Meyerhardt, Jennifer A Chan, et al.
Pageof 35

Showing results (191-200 of 350) with videos related to

Sort By:
Pageof 35
Pancreas|October 18, 2016
Precision Medicine and Pancreatic Cancer: A Gemcitabine Pathway ApproachJames J Farrell, Jennifer Moughan, Jonathan L Wong, et al.
American Journal of Cancer Research|April 6, 2019
Magnetic resonance imaging monitoring therapeutic response to dendritic cell vaccine in murine orthotopic pancreatic cancer modelsLiang Pan, Na Shang, Junjie Shangguan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2004
American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancerAl B Benson, Deborah Schrag, Mark R Somerfield, et al.
Journal of Oncology Practice|January 10, 2019
Piloting a Financial Counseling Intervention for Patients With Cancer Receiving ChemotherapySheetal M Kircher, Jessica Yarber, Josh Rutsohn, et al.
4Open|January 19, 2026
Safety and Efficacy of amplitude-modulated radiofrequency electromagnetic fields in advanced hepatocellular carcinomaArthur W Blackstock, Al B Benson, Masatoshi Kudo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2004
Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114Jeffrey A Meyerhardt, Joel E Tepper, Donna Niedzwiecki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803Shuji Ogino, Jeffrey A Meyerhardt, Natsumi Irahara, et al.
Cancer|July 2, 2003
The correlation between patient characteristics and expectations of benefit from Phase I clinical trialsKevin P Weinfurt, Liana D Castel, Yun Li, et al.
Hepatology (Baltimore, Md.)|November 24, 2011
Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: analyzing patterns of progression in 285 patientsSeanthan Senthilnathan, Khairuddin Memon, Robert J Lewandowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2010
Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803Kimmie Ng, Jeffrey A Meyerhardt, Jennifer A Chan, et al.
Pageof 35